Clinical trial registry record

Adapted Physical Activity and Prevention of Cardiovascular Risk in Elderly People Living With HIV:Comparative Study

A registered study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.

Plain-language guide

Five questions to ask about this record

What this is
A clinical study registration, not a result or recommendation.
Why it may matter
The registry currently reports Completed.
Evidence
Registered phase not reported study.
Main limitation
Registration does not prove that the intervention works, is safe, or is available to you.
What changed
Registry metadata was last updated January 21, 2022.
Where to verify
Open the primary registry below for eligibility, locations, contacts, and current status.
Registry ID
NCT05201417
Last registry update
January 21, 2022
Status
Completed
Phase
Phase not reported
Sponsor
Support and Education Technic Centre
Enrollment
112
Countries
Cameroon, France
Match confidence
100%
Source feed
ClinicalTrials.gov
Automated source synopsis

A registered study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.

Evidence snapshot

What the source actually supports

Evidence stage
Phase not reported
Study design
RANDOMIZED · PARALLEL · HEALTH SERVICES RESEARCH · NONE
Evidence population
Human clinical study registration
Participants
112
Population
ALL · 50 Years to 77 Years
Duration
2019-09-15 to 2020-06-08
Intervention
adapted physical activity
Comparator
control group A
Outcomes measured
heart failure — At inclusion and after 24 weeks; cardiovascular risks factors — At inclusion and after 24 weeks; total cholesterol ( mg/l) — At inclusion , up to 12 weeks and after 24 weeks; HDL cholesterol ( mg/dl) — At inclusion , up to 12 weeks and after 24 weeks; Triglyceride (mg/dl) — At inclusion , up to 12 weeks and after 24 weeks; atrial fibrillation-type heart rhythm disturbances — At inclusion and after 24 weeks; an indirect approach to the presence of sleep apnea — At inclusion and after 24 weeks; disturbances in the activity of the autonomic nervous system — At inclusion and after 24 weeks; inflammatry marker(Il-6) — At inclusion , up to 12 weeks and after 24 weeks; Cystatin C (mg/l) — At inclusion , up to 12 weeks and after 24 weeks; ultra sensitive CRP. — At inclusion , up to 12 weeks and after 24 weeks; gut microbiota — At inclusion and after 24 weeks; adapted physical activity — 12 weeks
Reported result
No reusable finding-level result is available in this record.

Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.

Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.

Source supportStructured registry protocol metadata; no finding-level conclusion is generated.

Trial stage · Phase not reportedA trial phase describes development stage; it does not establish a positive result.
Phase 1Phase 2Phase 3Phase 4

Registration and recruitment status do not establish safety, efficacy, or regulatory approval.

Why this record appears here · 100% topic match

The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.

  • Exercise · 100%Title contains controlled topic terminology. Summary contains controlled topic terminology. Source terminology contains a controlled topic term. Title supplies ageing or longevity context.

Automated source check 100% · update recency 50%. These figures help sort records; they are not medical ratings.

exercise
Read the original source →Export JSON